nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2C19—Sorafenib—thyroid cancer	0.125	0.18	CbGbCtD
Tranylcypromine—CYP1A2—Sorafenib—thyroid cancer	0.116	0.166	CbGbCtD
Tranylcypromine—CYP2C9—Sorafenib—thyroid cancer	0.104	0.15	CbGbCtD
Tranylcypromine—CYP3A4—Vandetanib—thyroid cancer	0.101	0.144	CbGbCtD
Tranylcypromine—CYP2D6—Sorafenib—thyroid cancer	0.0953	0.137	CbGbCtD
Tranylcypromine—CYP3A4—Sorafenib—thyroid cancer	0.0606	0.087	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—thyroid cancer	0.0578	0.0831	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—thyroid cancer	0.0368	0.0528	CbGbCtD
Tranylcypromine—Hypertensive crisis—Vandetanib—thyroid cancer	0.0321	0.106	CcSEcCtD
Tranylcypromine—Hypertensive crisis—Sorafenib—thyroid cancer	0.0217	0.0713	CcSEcCtD
Tranylcypromine—Blood pressure increased—Sorafenib—thyroid cancer	0.00602	0.0198	CcSEcCtD
Tranylcypromine—Pollakiuria—Vandetanib—thyroid cancer	0.00517	0.017	CcSEcCtD
Tranylcypromine—Bradycardia—Vandetanib—thyroid cancer	0.00456	0.015	CcSEcCtD
Tranylcypromine—Haemoglobin—Vandetanib—thyroid cancer	0.0045	0.0148	CcSEcCtD
Tranylcypromine—Haemorrhage—Vandetanib—thyroid cancer	0.00448	0.0147	CcSEcCtD
Tranylcypromine—Alopecia—Vandetanib—thyroid cancer	0.00396	0.013	CcSEcCtD
Tranylcypromine—Muscle spasms—Vandetanib—thyroid cancer	0.00375	0.0123	CcSEcCtD
Tranylcypromine—Vision blurred—Vandetanib—thyroid cancer	0.00368	0.0121	CcSEcCtD
Tranylcypromine—Tremor—Vandetanib—thyroid cancer	0.00365	0.012	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00348	0.0114	CcSEcCtD
Tranylcypromine—Loss of consciousness—Vandetanib—thyroid cancer	0.00343	0.0113	CcSEcCtD
Tranylcypromine—Hypertension—Vandetanib—thyroid cancer	0.00337	0.0111	CcSEcCtD
Tranylcypromine—Anxiety—Vandetanib—thyroid cancer	0.00331	0.0109	CcSEcCtD
Tranylcypromine—Dry mouth—Vandetanib—thyroid cancer	0.00325	0.0107	CcSEcCtD
Tranylcypromine—Oedema—Vandetanib—thyroid cancer	0.00318	0.0105	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00312	0.0103	CcSEcCtD
Tranylcypromine—Haemoglobin—Sorafenib—thyroid cancer	0.00304	0.01	CcSEcCtD
Tranylcypromine—Haemorrhage—Sorafenib—thyroid cancer	0.00302	0.00994	CcSEcCtD
Tranylcypromine—Insomnia—Vandetanib—thyroid cancer	0.00288	0.00947	CcSEcCtD
Tranylcypromine—Paraesthesia—Vandetanib—thyroid cancer	0.00286	0.00941	CcSEcCtD
Tranylcypromine—Tinnitus—Sorafenib—thyroid cancer	0.00282	0.00927	CcSEcCtD
Tranylcypromine—Flushing—Sorafenib—thyroid cancer	0.00281	0.00923	CcSEcCtD
Tranylcypromine—Decreased appetite—Vandetanib—thyroid cancer	0.00277	0.00911	CcSEcCtD
Tranylcypromine—Constipation—Vandetanib—thyroid cancer	0.00272	0.00896	CcSEcCtD
Tranylcypromine—Pain—Vandetanib—thyroid cancer	0.00272	0.00896	CcSEcCtD
Tranylcypromine—Alopecia—Sorafenib—thyroid cancer	0.00267	0.00879	CcSEcCtD
Tranylcypromine—Blood disorder—Epirubicin—thyroid cancer	0.00266	0.00876	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0026	0.00856	CcSEcCtD
Tranylcypromine—Muscle spasms—Sorafenib—thyroid cancer	0.00253	0.00832	CcSEcCtD
Tranylcypromine—Body temperature increased—Vandetanib—thyroid cancer	0.00252	0.00828	CcSEcCtD
Tranylcypromine—Abdominal pain—Vandetanib—thyroid cancer	0.00252	0.00828	CcSEcCtD
Tranylcypromine—Blood disorder—Doxorubicin—thyroid cancer	0.00246	0.00811	CcSEcCtD
Tranylcypromine—Anaemia—Sorafenib—thyroid cancer	0.00243	0.008	CcSEcCtD
Tranylcypromine—Syncope—Sorafenib—thyroid cancer	0.00236	0.00776	CcSEcCtD
Tranylcypromine—Leukopenia—Sorafenib—thyroid cancer	0.00236	0.00775	CcSEcCtD
Tranylcypromine—Loss of consciousness—Sorafenib—thyroid cancer	0.00231	0.00761	CcSEcCtD
Tranylcypromine—Asthenia—Vandetanib—thyroid cancer	0.00228	0.00751	CcSEcCtD
Tranylcypromine—Hypertension—Sorafenib—thyroid cancer	0.00227	0.00747	CcSEcCtD
Tranylcypromine—Dry mouth—Sorafenib—thyroid cancer	0.00219	0.00721	CcSEcCtD
Tranylcypromine—Diarrhoea—Vandetanib—thyroid cancer	0.00218	0.00717	CcSEcCtD
Tranylcypromine—Shock—Sorafenib—thyroid cancer	0.00211	0.00695	CcSEcCtD
Tranylcypromine—Dizziness—Vandetanib—thyroid cancer	0.0021	0.00693	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Sorafenib—thyroid cancer	0.0021	0.00692	CcSEcCtD
Tranylcypromine—Anorexia—Sorafenib—thyroid cancer	0.00205	0.00673	CcSEcCtD
Tranylcypromine—Vomiting—Vandetanib—thyroid cancer	0.00202	0.00666	CcSEcCtD
Tranylcypromine—Rash—Vandetanib—thyroid cancer	0.00201	0.0066	CcSEcCtD
Tranylcypromine—Dermatitis—Vandetanib—thyroid cancer	0.00201	0.0066	CcSEcCtD
Tranylcypromine—Headache—Vandetanib—thyroid cancer	0.00199	0.00656	CcSEcCtD
Tranylcypromine—Nausea—Vandetanib—thyroid cancer	0.00189	0.00622	CcSEcCtD
Tranylcypromine—Decreased appetite—Sorafenib—thyroid cancer	0.00187	0.00614	CcSEcCtD
Tranylcypromine—Pain—Sorafenib—thyroid cancer	0.00184	0.00604	CcSEcCtD
Tranylcypromine—Constipation—Sorafenib—thyroid cancer	0.00184	0.00604	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00176	0.00578	CcSEcCtD
Tranylcypromine—Urticaria—Sorafenib—thyroid cancer	0.00171	0.00561	CcSEcCtD
Tranylcypromine—Body temperature increased—Sorafenib—thyroid cancer	0.0017	0.00559	CcSEcCtD
Tranylcypromine—Abdominal pain—Sorafenib—thyroid cancer	0.0017	0.00559	CcSEcCtD
Tranylcypromine—Asthenia—Sorafenib—thyroid cancer	0.00154	0.00507	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—thyroid cancer	0.00152	0.005	CcSEcCtD
Tranylcypromine—Diarrhoea—Sorafenib—thyroid cancer	0.00147	0.00483	CcSEcCtD
Tranylcypromine—Dizziness—Sorafenib—thyroid cancer	0.00142	0.00467	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—thyroid cancer	0.0014	0.00462	CcSEcCtD
Tranylcypromine—Vomiting—Sorafenib—thyroid cancer	0.00137	0.00449	CcSEcCtD
Tranylcypromine—Rash—Sorafenib—thyroid cancer	0.00135	0.00445	CcSEcCtD
Tranylcypromine—Dermatitis—Sorafenib—thyroid cancer	0.00135	0.00445	CcSEcCtD
Tranylcypromine—Headache—Sorafenib—thyroid cancer	0.00135	0.00443	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—thyroid cancer	0.00129	0.00424	CcSEcCtD
Tranylcypromine—Nausea—Sorafenib—thyroid cancer	0.00128	0.0042	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—thyroid cancer	0.00124	0.00409	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—thyroid cancer	0.00119	0.00392	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—thyroid cancer	0.00119	0.00392	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—thyroid cancer	0.00116	0.00382	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—thyroid cancer	0.00115	0.00379	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—thyroid cancer	0.00114	0.00374	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—thyroid cancer	0.00112	0.00369	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—thyroid cancer	0.00112	0.00368	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—thyroid cancer	0.00112	0.00368	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00111	0.00366	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—thyroid cancer	0.0011	0.00363	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00107	0.00354	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—thyroid cancer	0.00105	0.00346	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—thyroid cancer	0.00104	0.00343	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—thyroid cancer	0.00104	0.00342	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—thyroid cancer	0.00104	0.00341	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—thyroid cancer	0.00103	0.0034	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—thyroid cancer	0.00103	0.0034	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00103	0.00338	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—thyroid cancer	0.001	0.0033	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—thyroid cancer	0.000987	0.00325	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—thyroid cancer	0.000964	0.00317	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—thyroid cancer	0.000959	0.00316	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—thyroid cancer	0.000935	0.00308	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—thyroid cancer	0.000927	0.00305	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—thyroid cancer	0.000916	0.00302	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—thyroid cancer	0.000913	0.00301	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—thyroid cancer	0.000899	0.00296	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—thyroid cancer	0.000894	0.00294	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—thyroid cancer	0.000872	0.00287	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—thyroid cancer	0.00087	0.00286	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—thyroid cancer	0.000865	0.00285	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—thyroid cancer	0.000859	0.00283	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—thyroid cancer	0.000855	0.00281	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—thyroid cancer	0.000848	0.00279	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—thyroid cancer	0.000839	0.00276	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—thyroid cancer	0.000832	0.00274	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—thyroid cancer	0.000827	0.00272	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—thyroid cancer	0.000825	0.00271	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—thyroid cancer	0.00081	0.00266	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—thyroid cancer	0.000807	0.00265	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—thyroid cancer	0.000805	0.00265	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—thyroid cancer	0.0008	0.00263	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—thyroid cancer	0.000795	0.00262	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—thyroid cancer	0.000794	0.00261	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000791	0.0026	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—thyroid cancer	0.000781	0.00257	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000777	0.00256	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—thyroid cancer	0.000777	0.00256	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—thyroid cancer	0.000775	0.00255	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000767	0.00252	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—thyroid cancer	0.000763	0.00251	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—thyroid cancer	0.000756	0.00249	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—thyroid cancer	0.000749	0.00246	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—thyroid cancer	0.000742	0.00244	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—thyroid cancer	0.00074	0.00244	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—thyroid cancer	0.000734	0.00242	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—thyroid cancer	0.000722	0.00238	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000719	0.00237	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—thyroid cancer	0.000718	0.00236	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—thyroid cancer	0.000717	0.00236	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—thyroid cancer	0.000713	0.00234	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00071	0.00234	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—thyroid cancer	0.000705	0.00232	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—thyroid cancer	0.0007	0.0023	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—thyroid cancer	0.00069	0.00227	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—thyroid cancer	0.000686	0.00226	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—thyroid cancer	0.000679	0.00223	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—thyroid cancer	0.000679	0.00223	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—thyroid cancer	0.000664	0.00219	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—thyroid cancer	0.000659	0.00217	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—thyroid cancer	0.000654	0.00215	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—thyroid cancer	0.000653	0.00215	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000649	0.00214	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—thyroid cancer	0.000638	0.0021	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—thyroid cancer	0.00063	0.00207	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—thyroid cancer	0.000628	0.00207	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—thyroid cancer	0.000628	0.00207	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—thyroid cancer	0.000627	0.00206	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—thyroid cancer	0.000627	0.00206	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000605	0.00199	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0006	0.00198	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—thyroid cancer	0.000583	0.00192	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—thyroid cancer	0.00058	0.00191	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—thyroid cancer	0.00058	0.00191	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—thyroid cancer	0.000569	0.00187	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—thyroid cancer	0.000543	0.00179	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—thyroid cancer	0.000527	0.00173	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—thyroid cancer	0.000525	0.00173	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—thyroid cancer	0.000505	0.00166	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—thyroid cancer	0.000502	0.00165	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—thyroid cancer	0.0005	0.00165	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—thyroid cancer	0.0005	0.00164	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—thyroid cancer	0.000497	0.00164	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—thyroid cancer	0.000486	0.0016	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—thyroid cancer	0.000471	0.00155	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—thyroid cancer	0.000467	0.00154	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—thyroid cancer	0.000463	0.00152	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—thyroid cancer	0.000463	0.00152	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—thyroid cancer	0.00046	0.00151	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—thyroid cancer	0.000436	0.00144	CcSEcCtD
